We have previously shown that the dysregulation of TGFβ signaling through inactivation of its receptors in stem cells is an early driver event in cSCC pathogenesis and plays a likely tumor suppressor role (Cammareri et al., 2016). This evidence concerns the gene TGFB1 and neoplasm.